176
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Predictive Value of Clinical and Laboratory Indices at First Assessment in Women Referred with Suspected Gestational Hypertension

, &
Pages 163-179 | Published online: 01 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Juan Tamargo, Ricardo Caballero & Eva Delpón. (2019) Pharmacotherapy for hypertension in pregnant patients: special considerations. Expert Opinion on Pharmacotherapy 20:8, pages 963-982.
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Josef M. Cortez, Athina Pappas, Adi L. Tarca, Piya Chaemsaithong, Zhong Dong, Lami Yeo & Sonia S. Hassan. (2014) Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine 27:2, pages 132-144.
Read now
Gianni Bellomo. (2012) Serum uric acid and pre-eclampsia: an update. Expert Review of Cardiovascular Therapy 10:6, pages 701-705.
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Zeynep Alpay Savasan, Juan Pedro Kusanovic, Giovanna Ogge, Eleazar Soto, Zhong Dong, Adi Tarca, Bhatti Gaurav & Sonia S. Hassan. (2011) Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 24:10, pages 1187-1207.
Read now

Articles from other publishers (21)

Pablo Stiefel, María L Miranda, Hada Macher, Luis M Beltran-Romero & Rocio Muñoz-Hernandez. (2017) Description of a strong relationship among total cell-free DNA levels, LDH values, AST values and platelet count in patients with HELLP syndrome. Hypertension Research 40:9, pages 843-845.
Crossref
Rocío Muñoz-Hernández, Pablo Medrano-Campillo, Maria L. Miranda, Hada C. Macher, Jose Manuel Praena-Fernández, Antonio J. Vallejo-Vaz, María J. Dominguez-Simeon, Rafael Moreno-Luna & Pablo Stiefel. (2017) Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome. American Journal of Hypertension 30:7, pages 673-682.
Crossref
Claire Mounier-Vehier, Jacques Amar, Jean-Marc Boivin, Thierry Denolle, Jean-Pierre Fauvel, Geneviève Plu-Bureau, Vassilis Tsatsaris & Jacques Blacher. (2017) Hypertension and pregnancy: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. Fundamental & Clinical Pharmacology 31:1, pages 83-103.
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Suzy Duckworth, Melanie Griffin, Paul T. Seed, Robyn North, Jenny Myers, Lucy Mackillop, Nigel Simpson, Jason Waugh, Dilly Anumba, Louise C. Kenny, Christopher W. G. Redman, Andrew H. Shennan & Lucy C. Chappell. (2016) Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study. Obstetrics & Gynecology 128:2, pages 245-252.
Crossref
Laura A. Magee, Peter von Dadelszen, Joel Singer, Terry Lee, Evelyne Rey, Susan Ross, Elizabeth Asztalos, Kellie E. Murphy, Jennifer Menzies, Johanna Sanchez, Amiram Gafni, Andrée Gruslin, Michael Helewa, Eileen Hutton, Shoo K. Lee, Alexander G. Logan, Wessel Ganzevoort, Ross Welch, Jim G. Thornton & Jean Marie Moutquin. (2016) Can adverse maternal and perinatal outcomes be predicted when blood pressure becomes elevated? Secondary analyses from the CHIPS (Control of Hypertension In Pregnancy Study) randomized controlled trial . Acta Obstetricia et Gynecologica Scandinavica 95:7, pages 763-776.
Crossref
Jean-Pierre Fauvel. (2016) Hypertensions et grossesse : aspects épidémiologiques, définition. La Presse Médicale 45:7-8, pages 618-621.
Crossref
Claire Mounier-Vehier, Jacques Amar, Jean-Marc Boivin, Thierry Denolle, Jean-Pierre Fauvel, Geneviève Plu-Bureau, Vassilis Tsatsaris & Jacques Blacher. (2016) Hypertension artérielle et grossesse. Consensus d’experts de la Société française d’hypertension artérielle, filiale de la Société française de cardiologie. La Presse Médicale 45:7-8, pages 682-699.
Crossref
Indira Álvarez-Fernández, Belén Prieto & Francisco V. Álvarez. (2016) Preeclampsia. Revista del Laboratorio Clínico 9:2, pages 81-89.
Crossref
Radwa Marawan AbdelHalim, Dalia Ibrahim Ramadan, Reham Zeyada, Ahmed Soliman Nasr & Iman Atef Mandour. (2016) Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study. Molecular Diagnosis & Therapy 20:2, pages 135-149.
Crossref
Luís Guedes-Martins. 2017. Hypertension: from basic research to clinical practice. Hypertension: from basic research to clinical practice 409 417 .
E. A. McCarthy, T. A. Carins, Y. Hannigan, N. Bardien, A. Shub & S. P. Walker. (2015) Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital. BMJ Open 5:11, pages e009492-e009492.
Crossref
L. Foo, J. Tay, C. C. Lees, C. M. McEniery & I. B. Wilkinson. (2015) Hypertension in Pregnancy: Natural History and Treatment Options. Current Hypertension Reports 17:5.
Crossref
Melanie Griffin & Andrew H Shennan. (2014) Clinical applications of biomarkers in preeclampsia. Biomarkers in Medicine 8:4, pages 459-470.
Crossref
Ines Kaufmann, Corinne Rusterholz, Irene Hösli, Sinuhe Hahn & Olav Lapaire. (2012) Can detection of late‐onset PE at triage by sflt‐1 or PlGF be improved by the use of additional biomarkers?. Prenatal Diagnosis 32:13, pages 1288-1294.
Crossref
Vikram Sinai Talaulikar & Hassan Shehata. (2012) Uric acid: is it time to give up routine testing in management of pre-eclampsia?. Obstetric Medicine 5:3, pages 119-123.
Crossref
Gianni BellomoSandro VenanziPaolo SaronioClaudio VerduraPier Luca Narducci. (2011) Prognostic Significance of Serum Uric Acid in Women With Gestational Hypertension. Hypertension 58:4, pages 704-708.
Crossref
K. Fukushima, M. Murata, K. Tsukimori, K. Eisuke & N. Wake. (2011) 8-Hydroxy-2-Deoxyguanosine Staining in Placenta Is Associated With Maternal Serum Uric Acid Levels and Gestational Age at Diagnosis in Pre-Eclampsia. American Journal of Hypertension 24:7, pages 829-834.
Crossref
. (2011) Current World Literature. Current Opinion in Obstetrics & Gynecology 23:2, pages 135-141.
Crossref
Fiona Milne. (2011) Action on Pre-eclampsia: Crisis and recovery. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1:1, pages 117-128.
Crossref
Alexander Heazell, Errol R. Norwitz, Louise C. Kenny & Philip N. BakerFiona Milne & N. Baker Philip. 2011. Hypertension in Pregnancy. Hypertension in Pregnancy 109 124 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.